J Korean Surg Soc.  2003 Jul;65(1):49-54.

Cyclooxygenase-2 Expression in Periampullary Cancer

Affiliations
  • 1Department of Surgery, Chungbuk National University Medical School, Cheongju, Korea. jwchoi@med.chungbuk.ac.kr
  • 2Department of Pathology, Chungbuk National University Medical School, Cheongju, Korea.

Abstract

PURPOSE
Cyclooxygenase-2 (COX-2) expression is up-regulated in several types of human cancers and it has been suggested that COX-2 is closely inked to carcinogenesis. The objectives of this study were to investigate COX-2 expression in periampullary cancer and to evaluate the association of the clinicopathological factors with its expression. METHODS: Thirty specimens which were resected from patients with periampullary cancers (13 pancreatic adenocarcinomas, 8 common bile duct cancers, 9 ampulla of vater cancers) were investigated by immunohistochemical staining using Anti COX-2 monoclonal Ab. The 30 specimens were divided into stain-positive and stain-negative groups. The correlation between COX-2 expression and the various clinicopathological factors including the tumor size, nodal metastasis, differentiation, perineural and vascular invasion, were studied. RESULTS: COX-2 was expressed in 69% of pancreatic adenocarcinomas, 100% of common bile duct cancers and 78% of ampulla of vater cancers. However there was no significant correlation between COX-2 expression and the clinicopathological factors. CONCLUSION: COX-2 is highly expressed in periampullary cancer. Even though there was no correlation with the clinicopathological factors, the utility of the COX-2 inhibitors in preventing or treating periampullary cancer remains undetermined but warronts further investigation.

Keyword

Cyclooxygenase-2; Periampullary cancer

MeSH Terms

Adenocarcinoma
Ampulla of Vater
Carcinogenesis
Common Bile Duct
Cyclooxygenase 2 Inhibitors
Cyclooxygenase 2*
Humans
Ink
Neoplasm Metastasis
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Full Text Links
  • JKSS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr